Omega Price To Sales Ratio vs Days Sales Outstanding Analysis

OHI Stock

USD 40.09 0.02 0.05%

Omega Healthcare financial indicator trend analysis is much more than just breaking down Omega Healthcare Inv prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omega Healthcare Inv is a good investment. Please check the relationship between Omega Healthcare Price To Sales Ratio and its Days Sales Outstanding accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Price To Sales Ratio vs Days Sales Outstanding

Price To Sales Ratio vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omega Healthcare Inv Price To Sales Ratio account and Days Sales Outstanding. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Omega Healthcare's Price To Sales Ratio and Days Sales Outstanding is -0.45. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Omega Healthcare Investors, assuming nothing else is changed. The correlation between historical values of Omega Healthcare's Price To Sales Ratio and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Omega Healthcare Investors are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Price To Sales Ratio i.e., Omega Healthcare's Price To Sales Ratio and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.45

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Omega Healthcare Inv stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Omega Healthcare sales, a figure that is much harder to manipulate than other Omega Healthcare Investors multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Days Sales Outstanding

Most indicators from Omega Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omega Healthcare Inv current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

As of now, Omega Healthcare's Selling General Administrative is increasing as compared to previous years. The Omega Healthcare's current Tax Provision is estimated to increase to about 3.4 M, while Issuance Of Capital Stock is projected to decrease to under 228.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.0B	861.3M	934.7M	981.5M
Total Revenue	1.1B	878.2M	949.7M	997.2M

Gross Profit Total Revenue

Omega Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Other Liab	Cash	Long Term Debt	Cash And Short Term Investments	Property Plant Equipment	Common Stock Total Equity
Total Assets		0.99	0.66	0.67	0.99	0.04	0.99	-0.8	0.99	0.65	0.6	0.82	0.97	0.98	0.9	0.99	0.71	0.16	0.08	0.89	-0.43	0.49	0.61	0.49	0.97	0.9
Short Long Term Debt Total	0.99		0.59	0.64	0.96	-0.04	1.0	-0.86	0.98	0.7	0.67	0.81	0.99	0.99	0.93	1.0	0.67	0.18	-0.04	0.89	-0.48	0.54	0.62	0.54	0.95	0.91
Other Current Liab	0.66	0.59		0.34	0.7	0.49	0.64	-0.17	0.59	0.04	0.03	0.44	0.54	0.6	0.51	0.6	0.84	-0.29	0.32	0.74	0.12	-0.19	0.3	-0.19	0.54	0.67
Total Current Liabilities	0.67	0.64	0.34		0.66	0.37	0.62	-0.49	0.68	0.22	0.17	0.76	0.68	0.58	0.43	0.65	0.38	0.72	0.2	0.5	0.03	0.5	0.53	0.5	0.63	0.54
Total Stockholder Equity	0.99	0.96	0.7	0.66		0.1	0.97	-0.74	0.98	0.6	0.54	0.81	0.94	0.96	0.86	0.96	0.72	0.13	0.18	0.87	-0.4	0.43	0.58	0.43	0.97	0.89
Property Plant And Equipment Net	0.04	-0.04	0.49	0.37	0.1		-0.02	0.44	-0.01	-0.73	-0.6	0.12	-0.07	-0.08	-0.25	-0.04	0.33	0.14	0.36	0.04	0.68	-0.41	0.18	-0.41	-0.01	-0.02
Net Debt	0.99	1.0	0.64	0.62	0.97	-0.02		-0.83	0.98	0.68	0.64	0.79	0.98	1.0	0.92	1.0	0.71	0.13	-0.02	0.9	-0.45	0.48	0.6	0.48	0.95	0.91
Retained Earnings	-0.8	-0.86	-0.17	-0.49	-0.74	0.44	-0.83		-0.83	-0.9	-0.88	-0.69	-0.89	-0.86	-0.9	-0.86	-0.35	-0.29	0.2	-0.71	0.71	-0.8	-0.61	-0.8	-0.81	-0.77
Non Current Assets Total	0.99	0.98	0.59	0.68	0.98	-0.01	0.98	-0.83		0.69	0.63	0.79	0.97	0.98	0.89	0.99	0.62	0.22	0.05	0.86	-0.48	0.54	0.6	0.54	0.97	0.89
Non Currrent Assets Other	0.65	0.7	0.04	0.22	0.6	-0.73	0.68	-0.9	0.69		0.86	0.47	0.72	0.73	0.79	0.7	0.18	0.09	-0.22	0.56	-0.8	0.69	0.3	0.69	0.67	0.62
Other Assets	0.6	0.67	0.03	0.17	0.54	-0.6	0.64	-0.88	0.63	0.86		0.45	0.7	0.69	0.8	0.67	0.25	0.03	-0.23	0.54	-0.83	0.7	0.46	0.7	0.61	0.6
Net Receivables	0.82	0.81	0.44	0.76	0.81	0.12	0.79	-0.69	0.79	0.47	0.45		0.83	0.79	0.73	0.82	0.71	0.35	0.18	0.68	-0.23	0.61	0.71	0.61	0.83	0.71
Common Stock Shares Outstanding	0.97	0.99	0.54	0.68	0.94	-0.07	0.98	-0.89	0.97	0.72	0.7	0.83		0.98	0.93	0.99	0.64	0.27	-0.01	0.87	-0.45	0.61	0.66	0.61	0.93	0.89
Non Current Liabilities Total	0.98	0.99	0.6	0.58	0.96	-0.08	1.0	-0.86	0.98	0.73	0.69	0.79	0.98		0.94	1.0	0.69	0.11	-0.04	0.89	-0.5	0.53	0.6	0.53	0.95	0.91
Other Stockholder Equity	0.9	0.93	0.51	0.43	0.86	-0.25	0.92	-0.9	0.89	0.79	0.8	0.73	0.93	0.94		0.93	0.64	0.02	-0.04	0.83	-0.61	0.57	0.7	0.57	0.87	0.86
Total Liab	0.99	1.0	0.6	0.65	0.96	-0.04	1.0	-0.86	0.99	0.7	0.67	0.82	0.99	1.0	0.93		0.68	0.18	-0.02	0.89	-0.47	0.55	0.62	0.55	0.95	0.91
Total Current Assets	0.71	0.67	0.84	0.38	0.72	0.33	0.71	-0.35	0.62	0.18	0.25	0.71	0.64	0.69	0.64	0.68		-0.28	0.22	0.76	-0.02	0.04	0.46	0.04	0.64	0.71
Short Term Debt	0.16	0.18	-0.29	0.72	0.13	0.14	0.13	-0.29	0.22	0.09	0.03	0.35	0.27	0.11	0.02	0.18	-0.28		0.0	-0.01	0.11	0.56	0.32	0.56	0.17	0.06
Intangible Assets	0.08	-0.04	0.32	0.2	0.18	0.36	-0.02	0.2	0.05	-0.22	-0.23	0.18	-0.01	-0.04	-0.04	-0.02	0.22	0.0		0.06	0.24	-0.19	0.04	-0.19	0.09	0.04
Common Stock	0.89	0.89	0.74	0.5	0.87	0.04	0.9	-0.71	0.86	0.56	0.54	0.68	0.87	0.89	0.83	0.89	0.76	-0.01	0.06		-0.32	0.3	0.48	0.3	0.81	0.99
Other Liab	-0.43	-0.48	0.12	0.03	-0.4	0.68	-0.45	0.71	-0.48	-0.8	-0.83	-0.23	-0.45	-0.5	-0.61	-0.47	-0.02	0.11	0.24	-0.32		-0.57	-0.29	-0.57	-0.53	-0.4
Cash	0.49	0.54	-0.19	0.5	0.43	-0.41	0.48	-0.8	0.54	0.69	0.7	0.61	0.61	0.53	0.57	0.55	0.04	0.56	-0.19	0.3	-0.57		0.56	1.0	0.57	0.4
Long Term Debt	0.61	0.62	0.3	0.53	0.58	0.18	0.6	-0.61	0.6	0.3	0.46	0.71	0.66	0.6	0.7	0.62	0.46	0.32	0.04	0.48	-0.29	0.56		0.56	0.64	0.53
Cash And Short Term Investments	0.49	0.54	-0.19	0.5	0.43	-0.41	0.48	-0.8	0.54	0.69	0.7	0.61	0.61	0.53	0.57	0.55	0.04	0.56	-0.19	0.3	-0.57	1.0	0.56		0.57	0.4
Property Plant Equipment	0.97	0.95	0.54	0.63	0.97	-0.01	0.95	-0.81	0.97	0.67	0.61	0.83	0.93	0.95	0.87	0.95	0.64	0.17	0.09	0.81	-0.53	0.57	0.64	0.57		0.85
Common Stock Total Equity	0.9	0.91	0.67	0.54	0.89	-0.02	0.91	-0.77	0.89	0.62	0.6	0.71	0.89	0.91	0.86	0.91	0.71	0.06	0.04	0.99	-0.4	0.4	0.53	0.4	0.85

Click cells to compare fundamentals

Omega Healthcare Account Relationship Matchups

Omega Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.8B	9.5B	9.6B	9.4B	9.1B	9.6B
Short Long Term Debt Total	5.1B	5.2B	5.3B	5.3B	5.1B	5.3B
Other Current Liab	312.0M	225.0M	268.4M	315.0M	112.0M	60.1M
Total Current Liabilities	437.0M	382.0M	268.5M	334.3M	663.1M	696.3M
Total Stockholder Equity	4.1B	3.8B	3.9B	3.6B	3.6B	3.8B
Property Plant And Equipment Net	(11.4M)	(10.8M)	(8.2M)	17.8M	30.2M	28.7M
Net Debt	5.1B	5.0B	5.2B	5.0B	4.6B	4.9B
Retained Earnings	(1.8B)	(2.3B)	(2.5B)	(2.7B)	(3.2B)	(3.0B)
Non Current Assets Total	8.6B	8.1B	8.2B	7.6B	8.3B	8.8B
Non Currrent Assets Other	7.3B	6.8B	6.9B	6.8B	7.5B	7.9B
Other Assets	830.5M	7.8B	7.4B	6.9B	6.0B	6.3B
Net Receivables	1.2B	1.1B	1.1B	1.5B	1.7B	1.8B
Common Stock Shares Outstanding	222.1M	235.1M	244.3M	244.3M	250.5M	263.0M
Liabilities And Stockholders Equity	9.8B	9.5B	9.6B	9.4B	9.1B	9.6B
Non Current Liabilities Total	5.0B	5.1B	5.3B	5.3B	4.7B	4.9B
Other Stockholder Equity	6.0B	6.2B	9.0B	9.1B	6.7B	7.0B
Total Liab	5.5B	5.5B	5.5B	5.6B	5.4B	5.6B
Total Current Assets	1.2B	1.4B	1.4B	1.8B	782.6M	664.3M
Short Term Debt	125M	101.2M	96K	19.2M	551.1M	578.7M
Intangible Assets	28.0M	1.9M	1.6M	1.4M	682K	647.9K
Common Stock	22.7M	23.1M	23.9M	23.4M	24.5M	12.3M
Accumulated Other Comprehensive Income	(39.9M)	(12.8M)	(2.2M)	20.3M	29.3M	30.8M
Other Liab	71.5M	10.8M	8.2M	21.8M	25.1M	23.9M
Cash	24.1M	163.5M	20.5M	297.1M	442.8M	465.0M
Long Term Debt	389.7M	369.5M	5.3B	5.3B	5.0B	5.3B
Cash And Short Term Investments	24.1M	163.5M	20.5M	297.1M	442.8M	465.0M
Property Plant Equipment	7.2B	6.7B	6.8B	6.5B	7.5B	7.9B
Common Stock Total Equity	22.7M	23.1M	23.9M	23.4M	26.9M	14.5M
Other Current Assets	(441.6M)	85.5M	(287.5M)	(486.7M)	107.7M	113.0M
Net Tangible Assets	3.5B	3.2B	3.3B	3.0B	3.4B	2.6B
Noncontrolling Interest In Consolidated Entity	201.2M	194.7M	201.4M	193.9M	223.0M	182.8M
Accounts Payable	5.1B	280.8M	268.5M	315.0M	362.3M	664.3M
Good Will	644.4M	651.7M	651.4M	643.2M	643.9M	456.7M
Retained Earnings Total Equity	(1.8B)	(2.3B)	(2.5B)	(2.7B)	(2.5B)	(2.4B)
Long Term Debt Total	389.7M	369.5M	5.3B	5.3B	6.1B	6.4B
Capital Surpluse	6.0B	6.2B	6.4B	6.3B	7.3B	4.5B

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:

How To Invest In Omega

Details

Is Omega Stock a good investment?

Details

What is Omega Healthcare's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.137

Dividend Share

2.68

Earnings Share

1.36

Revenue Per Share

4.03

Quarterly Revenue Growth

0.14

The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omega Price To Sales Ratio vs Days Sales Outstanding Analysis

Price To Sales Ratio vs Days Sales Outstanding

Price To Sales Ratio vs Days Sales Outstanding Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Days Sales Outstanding

Omega Healthcare fundamental ratios Correlations

Omega Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Omega Healthcare fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Net Debt
Total Liab	+ 1.0	Net Debt
Total Liab	+ 1.0	Non Current Liabilities Total
Cash And Short Term Investments	+ 1.0	Cash

Other Stockholder Equity	- 0.9	Retained Earnings
Non Currrent Assets Other	- 0.9	Retained Earnings
Common Stock Shares Outstanding	- 0.89	Retained Earnings
Other Assets	- 0.88	Retained Earnings
Total Liab	- 0.86	Retained Earnings
Non Current Liabilities Total	- 0.86	Retained Earnings